Rapid Bolus is a CO₂-powered handheld device that pressurizes IV pressure bags to 300 mmHg in under 5 seconds — replacing 30–60 seconds of manual hand-bulb inflation during massive hemorrhage resuscitation.
Get In TouchFlow restrictor, pressure relief valve, and downstream pressure-actuated shut-off valve prevent overpressurization — even with single-component failure.
Reach therapeutic 300 mmHg in approximately 3–5 seconds. Compatible with crystalloids, blood products, and irrigation fluids.
Pistol-grip form factor enables single-handed actuation while the clinician maintains hemorrhage control or performs other tasks.
Self-contained CO₂ cartridge. No batteries, no wall power, no compressed air lines. Ideal for austere, pre-hospital, and military environments.
Standard Luer-lock connection interfaces with existing IV pressure bags, tubing sets, and clinical workflows — no new infrastructure required.
From the MS single-use disposable to the ER-SP electronic reloadable with automated pump — a device optimized for every clinical setting.
Rapid Bolus addresses a universal clinical need across the continuum of care — from pre-hospital trauma and emergency departments to operating rooms, intensive care units, and military field medicine.
Modern massive transfusion protocols employ 1:1:1:1 ratios of packed red blood cells, fresh frozen plasma, platelets, and cryoprecipitate. Each of these blood components requires pressure infusion, significantly expanding the addressable device consumption per critical case.
Comprehensive coverage of all eight model variants, multi-layer safety architecture, and atmospheric reference spool valve IP.
Class II submission with verified predicate device (K974074, ZOLL Power Infuser). Voluntary clearance to strengthen market position.
Active component testing with precision valve manufacturer. Custom pressure relief valve development in progress.
30-month timeline from funding to first commercial sales, following FDA clearance and pilot manufacturing.
Our provisional patent filing provides comprehensive coverage across all device configurations — from mechanical single-use to electronic reloadable with automated pump control. Broad functional claims protect the core innovation while dependent claims cover specific embodiments.
A separate provisional application covers our atmospheric reference spool valve technology, which represents standalone licensable IP independent of the primary device.
We welcome inquiries from investors, potential strategic partners, and healthcare professionals interested in the Rapid Bolus platform.
info@rapidbolus.com